Home
Plasma
What is Plasma?
Plasma Collection
Manufacturing
Plasma Protein Therapies
Therapies
Who Needs Plasma Therapies?
Safety & Quality
Standards Programs
IQPP
QSEAL
Regulatory Policy
Overview
Regulatory Authorities
PPTA Regulatory Contributions
Pathogen Safety
Donor History Questionnaire
National Donor Deferral Registry
North America Programs
Patient Notification System
North America Data Program
European Programs
European Distribution Data
Meetings & Events
International Plasma Protein Congress
Plasma Protein Forum
International Plasma Awareness Week
PPTA Business Forum
PPTA Regulatory Workshop
PPTA Sponsored Symposia
Events Calendar
IPAW
Get Involved
Media Center
Partners
Presentations & Publications
PPTA Presentations
Publications
The Source
About Us
About PPTA
Mission
History
Boards of Directors
Current Members
Staff
Contact Us
Submit Your Question
Topics
Access to Care
Overview
U.S. Federal
U.S. State
Canada
Europe
Regulatory & Quality Policy
Overview
Regulatory Authorities
PPTA Regulatory Contributions
Communication & Advocacy
Free Trade
Plasma
Regions
North America
Europe
Asia
Rest of World
Home
Plasma
What is Plasma?
Plasma Collection
Manufacturing
Plasma Protein Therapies
Therapies
Who Needs Plasma Therapies?
Safety & Quality
Standards Programs
IQPP
QSEAL
Regulatory Policy
Overview
Regulatory Authorities
PPTA Regulatory Contributions
Pathogen Safety
Donor History Questionnaire
National Donor Deferral Registry
North America Programs
Patient Notification System
North America Data Program
European Programs
European Distribution Data
Meetings & Events
International Plasma Protein Congress
Plasma Protein Forum
International Plasma Awareness Week
PPTA Business Forum
PPTA Regulatory Workshop
PPTA Sponsored Symposia
Events Calendar
IPAW
Get Involved
Media Center
Partners
Presentations & Publications
PPTA Presentations
Publications
The Source
About Us
About PPTA
Mission
History
Boards of Directors
Current Members
Staff
Contact Us
Submit Your Question
Topics
Access to Care
Overview
U.S. Federal
U.S. State
Canada
Europe
Regulatory & Quality Policy
Overview
Regulatory Authorities
PPTA Regulatory Contributions
Communication & Advocacy
Free Trade
Plasma
Regions
North America
Europe
Asia
Rest of World
ARDS/ALI
Sort by title, date or author by clicking on the table headings "Title, Published Date and Author".
Filters
Display #
5
10
15
20
25
30
50
100
All
Filter
List of articles in category ARDS/ALI
Title
Published Date
Author
A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury.
Sunday, 14 August 2005 20:00
Written by Martin GS, et al.
Understanding and managing fluid balance in patients with acute lung injury.
Monday, 09 February 2004 19:00
Written by Lewis CA, et al.
Twenty-five percent albumin prevents lung injury following shock/resuscitation.
Monday, 29 September 2003 20:00
Written by Powers KA, et al.
Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury.
Tuesday, 29 October 2002 19:00
Written by Martin GS, et al.
Fluid balance and colloid osmotic pressure in acute respiratory failure: emerging clinical evidence.
Thursday, 12 October 2000 20:00
Written by Martin GS,
Immediate effects of albumin infusion in ill premature neonates.
Monday, 14 March 1988 19:00
Written by Greenough A, et al.
Membership
Join PPTA
Code of Ethics
Membership Levels
Benefits of Membership
Current Members
Plasma Products Databases
Albumin
Immunoglobulin
Alpha-1 Antitrypsin
Clotting Factors
Media and Information
The Source
Press Releases
PPTA Statements
Fact Sheets
Videos
Emergency Preparedness
Press Contact
Advocacy
Advocacy Toolkit
Patient Notification System
Patient Organizations
Access to Care
Patient Information Resources
Copyright © 2018 PPTA. All rights reserved. (202) 789-3100
Terms of Use
|
Privacy Statement
|
Sitemap